35 Burst results for "Eli Lilly"

Covid-19 Antibody Drug Cocktail From Eli Lilly Cleared for Use

10 10 WINS 24 Hour News

00:23 sec | 2 weeks ago

Covid-19 Antibody Drug Cocktail From Eli Lilly Cleared for Use

"Healthcare workers will have another tool in the fight against coronavirus correspondent Diane King Hall with the green light for Eli Lilly's Corona virus. Antibody treatment. The Food and Drug Administration gave emergency use authorization for its drug combination to treat mild to moderate cases of the coronavirus. Meanwhile, Eli Lilly CFO has resigned after revelations of inappropriate relationships with certain

Diane King Hall Eli Lilly Food And Drug Administration
Report: TikTok sale pushed by Trump is shelved

WSJ Minute Briefing

00:22 sec | 2 weeks ago

Report: TikTok sale pushed by Trump is shelved

"We report exclusively that the plan sale of tiktok s- american operations to a group including oracle and walmart is on hold while the biden administration reviews its policies on security last year. The trump administration order to ban on tiktok and told the video sharing apps chinese owner to divest itself of its. Us operations appeal that move which is still pending in court.

Tiktok S Biden Administration Tiktok Walmart Oracle United States
Covid-19 Antibody Drug Cocktail From Eli Lilly Cleared for Use

Glenn Beck

02:16 min | 2 weeks ago

Covid-19 Antibody Drug Cocktail From Eli Lilly Cleared for Use

"Well, I I met Dr Heath last week. Finally in person. I've been a part of the monoclonal antibody study that u A B Did. It's medicine that was given or not given either got the placebo or the medicine from Eli Lilly. And I understand now as we were talking about this doctor this past Friday that that medicine Is now actually being given to patients that come in sick. I just missed that window of decision. And so how is that going? How are people responding? And what is that medicine? So there's a couple of different medicines that are available there. All monoclonal antibodies, which is basically just an antibody, or an immune response has been created by a drug company. And you and many other people who contributed to these studies helped us determine that in particularly high risk patients, this decreases Hospitalizations by 70%. And so when we think about all the people who have had severe disease from this virus on by numbers of people that have passed away from this virus It is really a major breakthrough of giving a treatment in the outpatient setting very early in the disease course to try toe, decrease the severity of the disease and let people have a mild or course of illness. It's my understanding is that the way the drug works is the spikes on the actual cell of the Corona virus are what causes the replication in this drug attacks that and stops replication so beyond day five or six is it too late then The Corona virus is already you know, been passed that stage and has replicated Well, we sort of think about it is the horse out of the barn yet and if we can get it into people within the first five days that is most beneficial, but were actually allowed to give it in up to the 1st 10 days. After that, 10 day point, you start to have so much inflammation in the body that giving more anti viral or antibody type medicines may not be as beneficial and so our goal is to get people diagnosed as quickly as possible, referred as quickly as possible and treated as quickly as possible before the horse gets out of the

Dr Heath Eli Lilly
"eli lilly" Discussed on P&L With Pimm Fox and Lisa Abramowicz

P&L With Pimm Fox and Lisa Abramowicz

03:32 min | 3 weeks ago

"eli lilly" Discussed on P&L With Pimm Fox and Lisa Abramowicz

"And sarah just you know we could begin anywhere but i kind of like this headline on our live blog. It's says more juice to be squeezed in the land of the shorts. It's very intriguing headline are they're still shorts out there and are they hiding right now. Yes there are still shorts out there and you can just see that if you look at short interest as a percent of shares outstanding or as a percentage of float on many of these stocks. And you see some of the juice if we want to call it being squeezed this morning game. Stop for example. Currently up fifty nine percent cost the headphone maker up forty percent. Amc up forty six percent as we speak right now so after we did see the selloff yesterday brokerages placing restrictions now there has been an easing of those restrictions at the same time you have the likes of citron research coming out and saying that they are going to stop their short-selling research and we see a comeback in the making for many of these socks so sir we see the markets trading off today. Do we have evidence that part of this market movement. day-to-day here. This week has been in fact influenced by somebody's hedge funds looking to liquidate some of their bigger positions across the market to stave off some of the losses on these shorts evidence to that effect. So that is the understanding right now as a loose proxy if you look at an etf that trades under the ticker g. vip over the one two three four five. Six of the seven last days have been lower wednesday drop a four point three percent today we also see it down eight tenths of a percent. My colleague has actually written a lot about this too and she's got data i'm from goldman sachs prime broker unit and what it shows is that outflows from hedge funds and d. Grossing has actually been happening at the fastest rate since october of two thousand fourteen so there is some evidence that shows that hedge funds have had to de risk and you can see it in certain pockets of the market particularly like this. Etf which tracks favorite hedge fund long positions. Not only have. They been attacked on the short end of their book. They're having a hard time on the long end of the book to their explained to us a little bit more about the citron research decision. I zoom they're still going to short dogs. they're just not going to publish. Their research is that it had been opened before and then as part of that question. Does that leave us open to to fraud. Like for example enron and all of these other major fraudulent instances that we may not have found out about if there hadn't been shortsellers so what what citron said in their announcement was that they will focus on giving multi bagger opportunities for individual investors. Sow sure we'll get more information. My understanding is that yes. They're just not going to publish the research but then again we're still. This is still developing. I'm sure we'll get more information. But that's the issue right now. Why would any short seller wants to be an activist short. That publishes their shortlist if they know that read it community with now six million users is just going to gather to try to create a short squeeze and hurt their position. We know that the likes of citron other hedge funds that had short positions on some of these stocks have suffered billions of dollars worth of losses this week. And you see that culminating and citron's decision today halting twenty years of their short-selling analysis..

enron twenty years forty percent yesterday wednesday three percent forty six percent sarah today Six This week six million users this morning citron fifty nine percent this week october of billions of dollars seven last eight tenths of a percent
"eli lilly" Discussed on P&L With Pimm Fox and Lisa Abramowicz

P&L With Pimm Fox and Lisa Abramowicz

05:59 min | 3 weeks ago

"eli lilly" Discussed on P&L With Pimm Fox and Lisa Abramowicz

"It is time for bloomberg opinion today. We're joined by aaron brown calms for bloomberg opinion. Also the former chief risk manager at eight q r capital management based in new york city. Aaron thanks for joining us here. So as we take a look at this day trading phenomenon the game stops the. Amc's first of all. Are you surprised that a hedge fund the size and the expertise of melvin capital management with billions under assets under management. Are you surprised that they were hurt. So badly. the beginning of this you know no i'm not Shorting and market arbitrage has always been a very risky game and it's It's just par for the course normally you Make some easy money but once in a while you get killed on on a trade like this. It's just part of the short selling game. A little bit reminiscent of the right. I mean you would have imagined that he either wouldn't leave traces gay plotkin that is or that he would have some other kinds of trade. On that might mitigate any potential danger to this huge short well hedge funds. Have this type our business of taking risk of making big directional positions. And you do. Take your lumps sometime and we've seen some of the most successful traders. Lc good example. Amorth is another example. blow up and and all it takes is one bad trade. The people who are low risk people who are hedging everything who get out with stop losses Those people survive. but they don't make the giant prophets. Severi john paulson so aaron. I mean short-selling in short-squeezes have been around since the beginning of financial markets. I guess what's different about. This one is the advent and the use of social media number one and number two zero fee or zero commission trading which really opens it up to a much wider audience. Here are you surprised that robin hood your day and some other of these platforms chose to limit trading in some of these names. You know i wasn't surprised by robby. Robin hood has been under very intense regulatory pressure. A lot of suspicion. And i think you know robin hood is going to have to protect itself from this kind of thing..

Aaron Severi john paulson aaron robin hood today billions zero commission Amc new york city Robin hood aaron brown calms one bad trade first robin Amorth eight q r one melvin hood two
"eli lilly" Discussed on P&L With Pimm Fox and Lisa Abramowicz

P&L With Pimm Fox and Lisa Abramowicz

04:49 min | 3 weeks ago

"eli lilly" Discussed on P&L With Pimm Fox and Lisa Abramowicz

"A good news. Well it is a great pleasure right now to use the honorable david. Birds whose premier of bermuda possibly vivas job in verse premier birds. Thank you so much for joining and hope. Everybody is safe and well in bermuda. I know that bermuda was one of the places that managed to really control and restrain the this horrible horrible corona virus and for a very very longtime numbers were tiny and give us an update on that and how many people actually moves to bermuda to work from home. Oh well thank you. I mean. I know that we had an instant pleasure to be here with you. And you're listening audience. I know that we had over. Five hundred. Applications persons wanted to come to the country I think we had about three hundred fifty. Who actually arrived on island of this far Certainly there's people who are in an out And in bermuda right now. I think is our latest report. Last night we have Twenty nine asari. Twenty seven active cases of the coronavirus three persons in hospital. It was a little bit of an outbreak of that much has been controlled and i think over the last week We've we've reported on the one on new Local case the coronavirus. So i think we are in a good place We have we are. Bermuda is the fourth most tested country on the planet. Do testing here We we test test and test again so premier. I'm a huge fan of bermuda. Been there several times in that great look forward to coming back give us a sense of how the pandemic on a global scale has impacted tourism for. Bermuda have responded as well. Paul the pandemic. It's certainly had a great impact on tourism mom and recently of course with the flare ups that we've seen in the united states the united kingdom the new policies the biden administration cetera Seeding the Difficult period no question about it but this is our traditional low season tourism. So we just taking the time to recalibrate but we have events that are scheduled We have an international sailing regatta. That's going to be taking place review in march sale. Gp and we are. We have off sites which are happening from um you know. Companies in the united states. Who want to still you know travel and have their persons in a safe environment and have those things off. Sites or tourism industry is focusing more on the niche markets long-term tourists that people who are working From bermuda so in that case and instance That's that's how we are managing to recover and think that following that there's going to be Other chances for us. If the biden administration extends the no sale policy there are some cruise lines that are looking to possibly launch their cruises from here bermuda which is very close to the united states..

bermuda Bermuda three persons david last week Last night Twenty seven active cases one about three hundred fifty march Five hundred united states fourth most tested country Twenty nine asari biden administration united kingdom administration Paul
Lilly Antibody Drug Prevents Covid-19 in Nursing Homes, Study Finds

KYW 24 Hour News

00:33 sec | Last month

Lilly Antibody Drug Prevents Covid-19 in Nursing Homes, Study Finds

"Talk of vaccines. There hasn't been much talk of actually treating the illness and drugmaker Eli Lilly says that it's covert 19 antibody drug can prevent illness among residents and staff of nursing homes and other long term care facilities. It's the first major study to show that it may actually prevent the disease. The drug maker says the participants who got the drug had up to a 57% lower risk. Catching covert 19 now among nursing home residents. On Lee, there was an 80% reduction in risk. US regulators last year allowed emergency use of the treatment for mild and moderate covert 19 cases that do not require hospitalization. Meanwhile,

Eli Lilly LEE United States
Study: Eli Lilly's COVID-19 Antibody Protects the Most Vulnerable from Infection

Larry O'Connor

00:25 sec | Last month

Study: Eli Lilly's COVID-19 Antibody Protects the Most Vulnerable from Infection

"Eli Lilly says it's Potvin 19 antibody drug, meanwhile, can prevent illness among residents and staff of nursing homes and other long term care locations. Is the first major study to show that it may prevent disease. The drug maker says participants who received the drug head up to a 57% lower risk of getting Cove it among nursing home residents. Only there was up to an 80% reduction in

Potvin Eli Lilly
Lilly Antibody Drug Prevents Covid-19 in Nursing Homes, Study Finds

KNX Midday News with Brian Ping

00:44 sec | Last month

Lilly Antibody Drug Prevents Covid-19 in Nursing Homes, Study Finds

"On a covert 19 treatments. This is the first major study of Eli Lilly's Cove in 19 and a body drug treatment and those in nursing homes. In November, the FDA allowed emergency use of Eli Lilly's antibody drug as a treatment for milder moderate cases of covert 19. It's a one time treatment. It's given through an I V, V, the the company company says says among among nursing nursing home home residents residents who who got got the the drug. drug. Their Their risk risk was was reduced reduced by by as as much much as as 80% 80% residents residents and and staff staff who who got got the the drug drug head up to a 57% lower risk of getting Cove. It 19 nursing homes and other long term care facilities have been hit hard by the pandemic. Account for nearly 40% of the deaths. I'm Rita Foley, the top

Eli Lilly FDA Rita Foley
Lilly: Drug can prevent COVID-19 illness in nursing homes

Wintrust Business Lunch with Steve Bertrand

00:32 sec | Last month

Lilly: Drug can prevent COVID-19 illness in nursing homes

"Drugmaker Eli Lilly says it's covert 19 antibody drug can prevent illness among residents and staff of nursing homes and other long term care locations. It's the first major study to show that it may prevent disease, the drug maker, said participants who got the drug head up to a 57% lower risk of getting covert 19 among nursing home residents. Only there was up to 80% reduction in risk. US regulators last year allowed emergency use of the treatment for mild or moderate cove in 19 cases. Do not require hospitalization.

Drugmaker Eli Lilly United States
Lilly: Drug can prevent COVID-19 illness in nursing homes

AP News Radio

00:45 sec | Last month

Lilly: Drug can prevent COVID-19 illness in nursing homes

"There is promising new information on a code nineteen treatment this is the first major study of Eli Lilly's cove in nineteen antibody drug treatment and those in nursing homes in November the FDA allowed emergency use of the liabilities antibody drug as a treatment for mild or moderate cases of cove it nineteen it's a one time treatment is given through an IV the company says among nursing home residents who got the drug their risk was reduced by as much as eighty percent residents and staff who got the drug had up to a fifty seven percent lower risk of getting covert nineteen nursing homes and other long term care facilities have been hit hard by the pandemic the account for nearly forty percent of the deaths I'm Rita Foley

Eli Lilly FDA Rita Foley
Lilly Antibody Drug Prevents Covid-19 in Nursing Homes, Study Finds

KCBS Radio Morning News

00:14 sec | Last month

Lilly Antibody Drug Prevents Covid-19 in Nursing Homes, Study Finds

"And Eli Lilly drug is showing promising results in helping to prevent covert 19 and nursing homes, which have been hit hard by the coronavirus. The antibody therapy reduced residents risk of symptomatic covert 19 by as much as 80% in a

Eli Lilly
Dj vu in Alzheimer's research, and OWS's legacy

The Readout Loud

03:48 min | Last month

Dj vu in Alzheimer's research, and OWS's legacy

"Joe biden is heading to the white house. The us is grappling with an economic crisis and biotech is debating the amyloid hypothesis. Twenty twenty. one is starting off quite a bit like two thousand nine. Thanks in part to ally lilly and some surprising data on a new treatment for alzheimer's disease the biggest story coming out of j. p. morgan this week was news that a lily drug called banana managed to significantly slowed the progression of alzheimer's in small clinical trial. So why this is so notable denham ab like so many failed drugs before it is designed to attack toxic proteins in the brain called amyloid and that was reason enough to reignite the decade plus long argument over whether clearing out amyloid can actually make a difference for patients with alzheimer's disease so before we get into the implications of all that we should summarize what we actually know. Here's what lily disclosed in a study involving two hundred and seventy two patients with early stage alzheimer's those who got to non-arab some of their cognition and function decline. At a rate that was thirty two percent slower than those who got a placebo. The company used a metric called the integrated alzheimer's disease rating scale which we should note is a different measurement than what we've seen in past trials and that's about all the detail we got so far. Lilly said it would present full data at a conference in march. But until then we've only got a press release to go off of so i. I'm curious what you guys think. What are the implications of this. All the caveats that would apply to any alzheimer study. Let alone one this small but it arrives as we await word from the fda on a different Amyloid targeting treatment from biogen called which we spent a lot of time talking about on this podcast and then here comes this lily. News like a comet from the sky. How does this change kind of the state of play of amyloid so to me. This is just it's like deja vu right. it's we sort of fall into into this pattern of just keep recycling. The same arguments about the you know the efficacy of amyloid. Whether you're drugs that target amyloid are effective in alzheimer's and i i don't know what to make of these data. I i mean. I think what it says is that we will be having this debate for years to come. Even after we get a decision on atacama. I totally agree. I mean the sense of deja vu was so strong. I was looking back at articles trying to see what had happened through the years with these drugs targeting beta amyloid and i got back to you know twenty ten. When a lily drug called sima geza stat failed and there was this great npr story actually. Quoting bob langres who at the time was at forbes announced bloomberg my old colleague saying that this was really going to call into question the amyloid hypothesis. This was eleven years ago And we had daybreak on. Cnbc this week to talk with him. He's the ceo of eli lilly. And you know. He was the first one to note. How many failures. They've had in their thirty years of working on alzheimer's disease at the company. I'm focused on on this target One thing he noted that's different about this. Trial is its size. It was small and he said that was the reason he was more optimistic about the signal. They saw that they saw such a strong signal in a small study. Made him feel like it. Had to be an even stronger signal He noted that in the past they had gone to these very large phase three trials because they thought they would have to order to see a signal and here they did this small trial to see if this was even worth pursuing a before going to that big one so i thought that was pretty interesting but i also think we're still arguing over whether amyloid is a cause of alzheimer's or like jeff jonas. The former ceo of sage. Who's still at sage in a different role You know he. He's put it as he thinks. It's more like a scar or a scab where you pull it off. That doesn't fix the underlying wound. And we just don't have those answers yet

Alzheimer's Joe Biden Denham Lilly White House Banana Sima Geza Stat Morgan Biogen Bob Langres Lily Atacama FDA United States NPR Eli Lilly Bloomberg Cnbc
Lilly Alzheimer's Drug Helped Patients in Small Trial

CNBC's Fast Money

01:08 min | Last month

Lilly Alzheimer's Drug Helped Patients in Small Trial

"Let's check cheers of. Eli lilly topping the tape today. Rising nearly twelve percent some promising results from his alzheimer's drug metro got the details meg. Hey melissa results were surprised. This is a drug. That's face to relatively small study Early symptomatic alzheimer's disease and what they found was that this drug Helped slow the declines in cognition and function that you see with this alzheimer's disease by thirty two percent versus placebo. Now this is a drug that goes after those amyloid beta plaques in the brain the same approach we've seen the industry take over and over to no success and we should note that this is probably years from proving out to actually work and really get through the fda if it does provide in bigger trials but clearly providing a lot of hope today For the market. Anyway you also are seeing shares of biogen getting bullied on this news because they are up at the fda with their alzheimer's drug up six percent today Expecting a decision. I do kim ab march and that drug has the same mechanism of action not identical but also going after amyloid plaques smell So that was one of the big news

Alzheimer Eli Lilly Melissa FDA Alzheimer's Drug Biogen Kim Ab
Lilly Alzheimer's Drug Helped Patients in Small Trial

Glenn Beck

00:19 sec | Last month

Lilly Alzheimer's Drug Helped Patients in Small Trial

"Of cases worldwide, Eli Lilly is surging before the opening bell as it's experimental. Treatment for Alzheimer's disease showed promise. In a mid stage clinical trial, Lily said that patients with early Alzheimer's who received the drug showed significant slowing of decline in a measure of cognition and daily function. Compared with

Alzheimer's Eli Lilly Lily
Doses Of Antibody Drugs Remain Unused As They Present Various Challenges

All Things Considered

03:51 min | Last month

Doses Of Antibody Drugs Remain Unused As They Present Various Challenges

"The federal government says it has delivered more than 300,000 doses of monoclonal antibody drugs to help facilities nationwide. They're designed to treat patients with mild to moderate covert 19. The ideas keep those patients out of the hospital, but Many of those doses are sitting unused, due in no small part to the challenge of administering those drugs. NPR's science correspondent Richard Harris looks at to healthcare systems that have overcome those hurdles and are seeing hopeful results. Monoclonal antibodies present all sorts of challenges. They're given to people who have active infections, but who aren't hospitalized, so it's important to treat them without exposing other patients to risk. The drugs by Regeneron and Eli Lilly are also given by infusion, and that process takes a couple of hours. So when you add all this up, you know it's really a logistical challenge to deliver this therapy to a lot of people. But Dr Howard Long at Houston Methodist Hospital, says they figured out how to do that. They've opened clinics around Houston and doctors affiliated with the hospital are referring eligible patients. That is people who are over 65 or who have health conditions that put them at high risk. So at this point we're doing about 50 to 70 infusions a day, and patients are usually scheduled within a Relatively short period of time. So from the time they call into being infused, it's usually less than two days. The timing is important because these drugs appear to beam or effective early in the course of the disease. Mostly help people who aren't mounting their own strong immune reactions and, well medication sits unused in many locations around the country. That is not the case at his hospital, Hong says. Right now we're constrained more by the drug supply. They use it as fast as they get it. Any doctors nationwide aren't so enthusiastic about these drugs, though treatment guidelines issued by the National Institutes of Health say there's actually not good evidence to know whether they work. That's because the Food and Drug Administration relied on studies of just a few 100 patients to grant these drugs, emergency authorization. So these are very small numbers that under normal conditions nobody would never publish in the journal like New England Journal of Medicine. Yet this is, you know, kind of headline news. Welcome Toko bit time right. But doctors are gaining experience. Houston Methodist is now treated more than 1100 patients, Hong says. We're seeing results that are comparable to what was reported in the clinical trials by Eli Lilly and Regeneron about six or 7% of patients who are treated end up in the hospital or emergency room. He figures that without treatment about 15% of the most high risk patients could end up in the hospital or ER. Doctors affiliated with the Mayo Clinic or also encouraged by their experience. They've dust more than 2000 patients in Minnesota, Wisconsin, Arizona and Florida. Dr. Raymond reasonably has done a preliminary analysis of the 1st 1000 or so patients and finds low hospitalization rates. More importantly, there is some signal that is also reducing death. But again this our preliminary analysis we have to kind of make sure that this are all vetted by pure review. But this is what we're seeing. That's why we're happy. Unlike a clinical trial, this real world experience doesn't have a careful comparison group so doctors can't say for sure that these patients are faring better. Even so, these encouraging findings may be swaying doctors who weren't sure they wanted to refer their patients for treatment. There's nobody says patients are also becoming less skeptical. Initially, there were more declines than accept. But no, we're actually seeing more except than declines, and even though it takes a lot of person power to provide this treatment reasonably and Hong believe they're actually reducing the overall workload. Keeping patients out of the hospital. Richard Harris NPR

Regeneron Dr Howard Long Houston Methodist Hospital Eli Lilly Richard Harris NPR Houston Methodist Federal Government Hong Houston Dr. Raymond National Institutes Of Health Toko New England Journal Of Medicin Food And Drug Administration Mayo Clinic Wisconsin Minnesota
"eli lilly" Discussed on Women Making Waves Podcast

Women Making Waves Podcast

04:04 min | 2 months ago

"eli lilly" Discussed on Women Making Waves Podcast

"So well done. Thanks for having me. Thank you know we both cnn win cnn. And home thinking christmas essay a commercialized. Now you see at worst crowd increase. Oh you see it at home. Baking christmas commercialized. Now on save the vistan anxiety avenue. Impressive win new presence. Impose we files holly take a breakfast. Zayed's eats alley a depressant when of.

"eli lilly" Discussed on Women Making Waves Podcast

Women Making Waves Podcast

04:04 min | 2 months ago

"eli lilly" Discussed on Women Making Waves Podcast

"Is so well done. Thanks for having me. Thank you know we both cnn. Win cnn. And home thinking christmas essay a commercialized. Now bowl you see at worse crowd increase. Oh you see it at home. Baking christmas commercialized. Now save the vistan. Zayed's avenue impressive. Win new presence. Impose we files holly take a breakfast. Zayed's eats alley a depressant when of.

"eli lilly" Discussed on Women Making Waves Podcast

Women Making Waves Podcast

04:30 min | 2 months ago

"eli lilly" Discussed on Women Making Waves Podcast

"Sat in with each louisi- talk passionate and you are an indie folk singer. Songwriter under the name of flaming june vanden that started in nineteen ninety five with various fantastic lineups. Now you'll brand is no stranger to success you and the ban had been on the bbc's music airplay won various awards receiving praise from prestigious authors and you supported big country elisa carthy ed sheeran and many many others and sang fantastic festivals. All over the place. Now you've formed a band. And i cannot believe i'm saying this. The word christmas wonderfully you're releasing a comedy christmas single with a mental health focus and yeah making a donation to charity in new year. Now i'd say it was a couple of years ago when we featured you on women making ways it's an absolute pleasure to welcome you back louise and somebody to be. Thanks potential of a enter. It makes me makes me quite successful. I'm not used to that so you are you you. Why a new band and why is comedy part of this single case well. I didn't really want to release it under flaming jim because as as kind of a one off and something sort of separate from the flaming june kind of stuff and it's all my rights. Ten years ago officer particularly awful year and i was in a bad situation. And we've made me i i. I can't take things. They really even when things are serious. So i kind of read that song to make light of my situation there. There wasn't really anything to make light off. In hindsight the i had to find a way of three and a way to express it and Yeah it came out in that song. Yeah christmas ten years ago ten years ago so this extraordinary and it's amazing thing is how he poets aren't your poets singers. You write songs. You keep her sort of a log of what you've been through and then you can retrieve and go back into it can't definitely yes and if you're like me and you don't learn from your mistakes you know. I don't need to write nissan's anymore. I kind of just regurgitate the ones i wrote. Last time i made that mistake and we are shingle is lovely. I mean we ve been lucky enough to hear your cold thing is. Elliott lillies search. The eli lilly's and yes. Well i think that's how they say it but it's based on Because i like everything to links so it's based on the pharmaceutical company lily which is spelt differently. The little bits felt differently but they were the first company to manufacture prozac in the nineteen eighty s. Say the bond name kind of linked to the subject matter. I suppose so. Yeah we want to see a to make where we couldn't think rebounding really. That was the main reason. Andy still dot that linked not said it's like the his the history of anti-depressants is is a very modern. It's only eighty cents. Eighty s the certain medicines have been available of revolutionized really the treatment of mental health. And it may not only very recently by the eighties. That's no time is it. So yes everyone linked to history of treatments. I suppose speed the band name and of course people are suffering at the moment. Aren't they dones. And and couvert which is frightening people as well in case yes very relevant to do this at the moment. Well ahead say because i'm christmas. Christmas is obviously a lovely time can be is also very difficult time for love people and hopefully this kinda tongue-in-cheek song which is tackling a serious subject but it is hurtful funny. I'm hoping it will bring something that people can relate to and so of lift people slightly because obviously two thousand hundred twenty s not been a great year and christmas is tough for some people anyway and we've grown up and everything else. I can imagine that a lot of people will find christmas pretty tough this year. So hopefully it'll be a bit.

elisa carthy ed sheeran Elliott lillies bbc louise jim eli lilly nissan Andy
"eli lilly" Discussed on Women Making Waves Podcast

Women Making Waves Podcast

04:30 min | 2 months ago

"eli lilly" Discussed on Women Making Waves Podcast

"Sat in with each louisi- talk passionate and you are an indie folk singer songwriter. Under the name of flaming june vanden that started in nineteen ninety five with various fantastic lineups and brand is no stranger to success you and the ban had been on the bbc's music airplay won various awards receiving praise from prestigious authors and you supported. Big country elisa carthy ed sheeran and many many others and sang fantastic festivals. All over the place. Now you've formed band. And i cannot believe i'm saying this. The word christmas wonderfully you're releasing a comedy christmas single with a mental health focus and yeah making a donation to charity in new year. Now i'd say it was a couple of years ago when we featured you on women making ways it's an absolute pleasure to welcome you back louise and somebody to be back in. Thanks for such a enter. It makes me makes me quite successful. I'm not used to that so you are you you. Why a new band and why is comedy part of this single case well. I didn't really want to release it under flaming jim because as as kind of a one off and something sort of separate from the flaming june kind of stuff and it's song right ten years ago officer particularly awful year and i was in a bad situation. And we've made me i i. I can't take things. They really even when things are serious. So i kind of read that song to make light of my situation there. There wasn't really anything to make light off. In hindsight the i had to find a way of three and a way to express it and Yeah it came out in that song. Yeah christmas ten years ago ten years ago so this extraordinary and it's amazing thing is how he poets aren't your poets singers. You write songs. You keep her sort of a log of what you've been through and then you can retrieve and go back into it can't definitely yes and if you're like me and you don't learn from your mistakes you know. I don't need to write nissan's anymore. I kind of just regurgitate the ones i wrote. Last time i made that mistake and we are shingle is lovely. I mean we ve been lucky enough to hear your cold thing is. Elliott lillies search. The eli lilly's and yes. Well i think that's how they say it but it's based on Because i like everything to links so it's based on the pharmaceutical company lily which is spelt differently. The little bits felt differently but they were the first company to manufacture prozac in the nineteen eighty s. Say the bond name kind of linked to the subject matter. I suppose so. Yeah we want to see a to make where we couldn't think rebounding really. That was the main reason. Andy still dot that linked not said it's like the his the history of anti-depressants is is a very modern. It's only eighty cents. Eighty s the certain medicines have been available of revolutionized really the treatment of mental health. And it may not only very recently by the eighties. That's no time is it. So yes everyone linked to history of treatments. I suppose speed the band name and of course people are suffering at the moment. Aren't they dones. And and couvert which is frightening people as well in case yes very relevant to do this at the moment. Well ahead say because i'm christmas. Christmas is obviously a lovely time can be is also very difficult time for a love people and hopefully this kinda tongue-in-cheek song which is tackling a serious subject but it is hurtful funny. I'm hoping it will bring something that people can relate to and so of lift people slightly because obviously two thousand hundred twenty s not been a great year and christmas is tough for some people anyway and we've grown up and everything else. I can imagine that a lot of people will find christmas pretty tough this year. So hopefully it'll be a bit.

elisa carthy ed sheeran Elliott lillies bbc louise jim eli lilly nissan Andy
US to start distributing experimental virus drug

AP News Radio

00:53 sec | 3 months ago

US to start distributing experimental virus drug

"It's just been approved for emergency usage by the FDA now the government shipping an experimental drug the second anybody treatment for coronavirus patience health and Human Services secretary Alex a stark says the government will start distributing doses of an experimental anybody drug to fight Kobe nineteen it's the same one president trump received last month we expect to distribute about thirty thousand doses of the Regeneron product tomorrow with more to come in the ensuing weeks it's given as a one time IV treatment a coronavirus patients who are at high risk of developing serious illness Dr Janet woodcock and FDA adviser to operation warp speed says studies suggest the drug can reduce the pressure on hospital systems CBOE high risk patient had a nine percent chance of hospitalization or even death that persists three percent of treated individuals earlier this month the FDA allowed similar use of drug from Eli Lilly Jennifer king Washington

Coronavirus Patience Health An Regeneron FDA Dr Janet Woodcock Stark Kobe Alex Cboe Eli Lilly Jennifer King Washington
FDA allows emergency use of antibody drug Trump received

KNX Weekend News and Traffic

00:51 sec | 3 months ago

FDA allows emergency use of antibody drug Trump received

"Food and Drug Administration authorized emergency use of an antibody drug to help the immune system fight covert 19. Antibody cocktail from Regeneron was used by President Trump after he tested positive for the virus. Dr. Celine Gounder is a member of President elect Biden's coronavirus task force. This is an important tool in our toolbox. It's important to understand, so this is being approved for patients with mild to moderate disease. Generally people who are very early in the course of disease. So there's these air, not patients who are on a ventilator. This is not a Hail Mary kind of treatment. The doctor tells CNN. This kind of treatment is not going to work until the country scales up testing so they're positive cases can be picked up. Early. Earlier this month, the FDA gave emergency authorization to a single antibody drug from Eli Lilly. It is also still being studied.

Regeneron Dr. Celine Gounder President Elect Biden Food And Drug Administration CNN Eli Lilly
Covid Milestones: Eli Lilly CEO on Antiviral Approval & Pfizers FDA Application

Squawk Pod

04:34 min | 3 months ago

Covid Milestones: Eli Lilly CEO on Antiviral Approval & Pfizers FDA Application

"Corona virus cases are hitting new highs in the united states and the cdc is urging the country to keep thanksgiving celebrations small. The recommending americans spend the holiday only with people who've been living in their households for the last fourteen days which means no military personnel. Who plant to come home and no college students back from campus. And this week amid it. All california governor gavin newsom issued a curfew between ten pm and five am for all nonessential work and gatherings in most of the state and the order will remain in place until at least december twenty first perhaps even longer but some good news today as well visor and its partner. Biontech are submitting their obligation to the fda for emergency use authorization of their covid nineteen vaccine. This would be the first covid vaccine that goes through the regulatory process. Here's becky the fda's review process is expected to take a few weeks. Advisory committee meeting on the vaccine is tentatively scheduled for early next month. If it's approved some americans could get their first doses in just about a month's time earlier this week study. Data analysis showed this vaccine to be ninety five percents effective and that's incredibly impressive. Let's bring in meg. Terrell she's got more on this good morning. Good morning becky moving incredibly fast and a really historic milestone this morning the first vaccine to go to the fda for covid nineteen to try to stop this pandemic. So we're going to see this regulatory process. Really play out over the coming weeks. We should here typically the way this works is the company alerts the world when the fda has accepted an application and set a date to decide on the drug. We're in a pandemic of course so those dates are not going to be normal. And the communications might be different to we. Might hear from the fda Either the decision timing that they might be looking at and especially about when they're gonna set that advisory committee meeting to discuss this vaccine. That's when outside advisers get together dig apart all of the data around The vaccine the safety the efficacy the manufacturing and talk about also how this should potentially be approved for the market. And it's possible. We will see an application from dern. They said within weeks So we should see that soon. Too and so the expectation that i heard was that the fda had asked those outside advisors to set aside december eighth ninth and tenth three days to potentially discuss. Both vaccines Now dr john taurus from nbc had the fda commissioners steven hahn said scott gottlieb. Stephen hawking on with him yesterday in a facebook live. He asked him about those dates. Any no he said. The fda was going to be flexible. He wouldn't confirm that they had asked them to set those dates. And so we have been hearing since we reported those dates a lot of people sort of saying. Why is this going to take so long So we will have to wait to see what the empty actually does In terms of scheduling that meeting. They do need time to go through the application themselves very carefully. Prepare the documents the committee and then the committee will discuss it and we do expect the fda decide extremely quickly after that meeting Whether to green light this market and then pfizer in biontech. Say they are ready to go within hours after that That green light to start shipping. This guy's yeah. That was one of the things that really caught my attention this morning. The idea that within hours they'd be ready to start shipping vaccine and getting it out there and that brings up the question of how we do that. How do we distribute this. Where does it go. How do we determine who gets it. I never the states have been working on plans along with the federal government to try and figure out how much each state would get. But how does it work. We do even know. Do we have a real game plan for who gets what. When and how we know part of that. So operation warp speed an eighty just secretary alex as are held. A briefing about those plans are earlier. This week And essentially what would happen after. The fda gives the green light if it does then. The cdc has an advisory committee as well that would meet to make recommendations about. Who should get this vaccine. I if there are two vaccines if there are any differences in them you know which groups should get which dosing of that stuff So that's expected to happen extremely quickly. And then the cdc makes recommendations about how much each state should get Secretaries are based on population. We also know of course that because supply will be so limited that there are going to be prioritized groups. Healthcare workers are expected to be at the top People with underlying health conditions that make them more severe. More vulnerable to severe disease will also be at the top so We'll see how that gets allocated to the states based on what. The group recommends

FDA Becky Gavin Newsom CDC Dr John Taurus Steven Hahn Scott Gottlieb Terrell Biontech Dern United States California NBC Stephen Pfizer Facebook Federal Government Alex
"eli lilly" Discussed on KTRH

KTRH

03:04 min | 3 months ago

"eli lilly" Discussed on KTRH

"Healthcare workers, including some here in Houston, are likely to receive that vaccine first. The first treatment for people who already have cove It has arrived in Texas Governor Greg Abbott made that announcement today. It is the Eli Lilly anti body therapeutic treatment is like the drug that was taken by the president that helped him recover so quickly from over 19. Now, the governor says that treatment for people who already have cove it will serve two purposes. The goal is to both hell Texans as well as to ease the burden on hospitals in just the coming weeks. The antibody treatment is now being distributed across every region here in the state. The World Health Organization may soon be butting heads with the top health officials here in the United States over the covert treatment, the W. H O was telling doctors around the world not to use the drug given to President Trump. It's called rim disappear, and they claim it doesn't help. That goes directly against the FDA, which signed off on the drug last month for patients here in the United States. Even infectious disease expert Dr Anthony Fauci at the White House says the drug does help in treatment. George's secretary of state is poised to certify the state's election results tomorrow. Results of a hand recount confirmed the initial outcome with Joe Biden leading president Trump even after the results are certified, which hasn't happened. Yet. The Trump campaign still has a few days to request another recount that would be done using scanners instead of by hand. Joe Biden is not officially the president elect as Trump's team as ongoing legal battles in multiple other states nevertheless, by and says he will announce his pick for Treasury secretary student Speculation is that he will pick former Federal Reserve Chair Janet Yellen Ktrh news time 803 12 million Americans could lose their unemployment benefits the day after Christmas to programs of the cares act, the Pandemic Unemployment assistant program in the pandemic. Emergency unemployment compensation are scheduled to expire before the end of the year. Two programs account for more than half of the 21 million people receiving some form of unemployment benefits. Republicans and Democrats have been at an impasse over a new covert relief bill for months, and it's unclear if Congress will pass an extension for those two programs. And feeding the family. Thanksgiving this year will likely not take as much out of your wallet. A new report shows. A turkey day feast for 10 will cost an average of about $47 this year down from $49 in 2019. The average cost of this year's Thanksgiving dinner is the lowest in a decade. And finally, if you're hitting the roads for Thanksgiving, you won't be paying more for gas. Triple A says Lower demand and steady crude oil prices are keeping pump prices here in Texas in check. Houston's average rose a penny this week to a dollar 77 per gallon. More news on demand to ktrh Qamar Next update at 8 30 Breaking information as it happens up next more Marchal event I'm Wyatt Goolsbee on NewsRadio. 7 40 ktrh rules. They're made to be broken,.

President Trump Joe Biden president United States Greg Abbott Texas Houston Pandemic Unemployment Eli Lilly Dr Anthony Fauci World Health Organization FDA Wyatt Goolsbee Janet Yellen Ktrh Congress
Eli Lilly’s Antibody Treatment Gets Emergency F.D.A. Approval

The KFBK Morning News

00:37 sec | 3 months ago

Eli Lilly’s Antibody Treatment Gets Emergency F.D.A. Approval

"Emergency youth authorization for its covert 19 treatment. Here's Eli Lilly CEO David A. Ricks, on who it will help but the first drug ever to be designed for beating back over 19. It's indicated in early diseases you're saying so within the 1st 10 days of symptoms. And we really wanted targeted to those with high risk factors. This is an antibody treatment. It could only be used in patients 12 years old and older who have mild to moderate cases of the disease. They also must face a high risk of getting worse. It is not intended for patients who are already hospitalized with visors. Optimistic Vaccine

David A. Ricks Eli Lilly
"eli lilly" Discussed on KOA 850 AM

KOA 850 AM

01:56 min | 3 months ago

"eli lilly" Discussed on KOA 850 AM

"Decade old law that now does not have a penalty for refusing to buy insurance. Congress got rid of the penalty three years ago Republican led against arguing the health care law is unconstitutional. Supporters say getting rid of it would deprive more than 20 million Americans of Health insurance. A decision is expected next year. Even though death rates are down from the start of the pandemic, state epidemiologist Dr Rachel Herlihy telling Keohane news radio. The virus is still much more dangerous than influenza. We see fatality rates in the 1 to 2% range, and that's actually pretty severe. And in addition to that, we know that there are lots of individuals that are experiencing long term impact, not just a quick infection that people get over their lasting consequences. Having Dr Hurley he says hospitalization rates are as high as they've been since the spring, a day after a potential Corona virus vaccine may soon be ready for market. Eli Lilly, announcing a new therapeutic antibody for covered 19 will be sent to hospitals for use in treating patients. Hamlin Nivea Mabon Antibody based treatment developed by Eli Lilly is now headed into the health care system granted an emergency use authorization by the Food and Drug Administration. The product distribution will begin this week and will be working with state local a territorial health department. So the patients can receive the fusion in hospital, outpatient or alternate carry US Health and human services Secretary Alex Cesar. The medicine is already bought and paid for under operation Warp speed, but patients could be charged a fee for administering it. HHS says they're working to alleviate that out of pocket cost. Evan Brown FOX News, Mitch McConnell was asked today about Donald Trump, not conceding the presidential race, not unusual. Should not be alarming. At some point here, we'll find out finally. Who was certified in each of these states in the electoral.

Eli Lilly Dr Hurley Dr Rachel Herlihy Congress Food and Drug Administration HHS state epidemiologist Donald Trump Alex Cesar Evan Brown Mitch McConnell Secretary
US allows 1st emergency use of a COVID-19 antibody drug

The Vegas Take

00:21 sec | 3 months ago

US allows 1st emergency use of a COVID-19 antibody drug

"Eli Lilly's Corona virus antibody treatments approved for emergency used by the Food and Drug Administration's drug works by preventing the virus from entering human cells. It is only for patients with a mild form of the virus. The company in a press release, said Bam Lane of a mob should be administered as soon as possible after a positive covert 19 tests and within 10 days of symptom onset. David Miller, Americans

Eli Lilly Food And Drug Administration Bam Lane David Miller
"eli lilly" Discussed on 77WABC Radio

77WABC Radio

02:23 min | 4 months ago

"eli lilly" Discussed on 77WABC Radio

"Jack Callahan Fox News Late into the evening, members of the Senate Judiciary Committee peppered with questions the president's Supreme Court nominee on the first day of direct questioning before the Senate Judiciary Committee, Supreme Court nominee Judge Amy Cockney Barrett. Refused to commit to rule in any particular way should she be confirmed to the nation's highest court. She also stressed that no one within the Trump administration, including the president has asked her to. I have had no conversation with the president or any of his staff. On how I might rule in that case in round one senators are allotted 30 minutes and at least one of them, Democratic Senator Sheldon Whitehouse didn't ask a single question. Instead calling into question the donors and organizations now supporting barrettes nomination. Fox's Shannon Bream, the president, telling a big campaign rally outside Pittsburgh Tuesday night, the judge Barrett is making a great impression, but warning his opponent has other plans for the high court. Now, Biden even refuses to answer questions unpack in the Supreme Court. You know, Elections have consequences, winning and losing an election. That's big consequences and we've been winning elections. President says he's feeling well after testing negative for the Corona virus, But Joe Biden told a campaign event near Fort Lauderdale reckless personal conduct since his diagnosis is unconscionable. Longer. Donald Trump is president more reckless. He seems to get Thank God we only have three weeks left to go. President has another rally scheduled Wednesday in Des Moines, Iowa. Independent monitors have paused enrollment in a study testing the antiviral drug room disappear, plus an experimental antibody therapy for the Corona virus. Drugmaker Eli Lilly, confirming the study is paused out of an abundance of caution. Wall Street Tuesday the Dow dropped 157 points. NASDAQ Lost 12, the S and P 500 down 22 points. America is listening to Fox News. From the Fox News broadcasts Network download and make it hammer time with Bill Hemmer, Steve Cortes, senior advisor Trump Campaign. I believe that there is a reluctance of people to say they're going to vote for Donald Trump. Because of the unfortunate Cancel culture is so pervasive in our society. There could be sanctions against people social work. Thanks. Otherwise, I don't want to rely on this, but I think it's reasonable to posit that there is a certain trump reluctant voter out there. Subscribe and listen.

president Donald Trump Supreme Court Judge Amy Cockney Barrett Joe Biden Senate Judiciary Committee Trump Campaign Fox News Senator Sheldon Whitehouse Jack Callahan Fox Eli Lilly Des Moines Shannon Bream Bill Hemmer Iowa Fort Lauderdale America
"eli lilly" Discussed on KLBJ 590AM

KLBJ 590AM

01:51 min | 4 months ago

"eli lilly" Discussed on KLBJ 590AM

"Concerns over the affordable care act. I least Scylla Sarah Fox News on Day two hearing for Amy Cockney Barrett, President Trump's choice for the Supreme Court. Many Democrats, including vice presidential nominee Camel, Harris, expressed concerns about whether the would be dismantled. Trump Administration and Senate Republicans are urging the Supreme Court to strengthen the entire affordable care act and all of its patient protection. Judge Barrett said earlier today it's up to the courts to interpret the legality of the statue. Structure, the affordable care act. It's a complex long statute. I think you set the policy and then I think when a court has to interpret the statute or decide how it applies in a certain circumstance Court looks tradition. Traditional legal materials looks for the briefs. The hearing continues tomorrow morning with a procedural vote plan for Thursday. President Trump weighing in on the proceedings while campaigning in Johnstown, Pennsylvania, will tell you Amy's made a great impression. The president's opponent, former Vice President Joe Biden, was in Florida today. A state the president narrowly won in 2016. Tomorrow, the president has to Iowa Independent monitors have paused enrollment in the study, testing the covert 19 antiviral drug Ram death severe plus an experimental antibody therapy being developed by Eli Lilly. It's similar to the treatment President Trump received last week when he was diagnosed with the virus. That company says it paused the enrollment out of an abundance of caution and says safety is his main concern. Supreme Court has effectively stopped the senses from continuing through the end of October, The Trump Administration had asked the high court to suspend the lower court order permitting the 2020 senses to continue through the end of the month. Associate Justice Sonia Sotomayor dissented. Writing meeting the deadline at the expense of the accuracy of the senses.

President Trump Supreme Court Amy Cockney Barrett Trump Administration president Vice President Court Sonia Sotomayor Sarah Fox Eli Lilly Joe Biden Johnstown Harris Senate Iowa Pennsylvania Florida
"eli lilly" Discussed on Progressive Talk 1350 AM

Progressive Talk 1350 AM

05:40 min | 4 months ago

"eli lilly" Discussed on Progressive Talk 1350 AM

"Of that essentially clothes that antibody and make bigger quantities of it and then If using people to test it. And so that's what Eli Lilly has done. Mourning a sound was Peter Loftiest Healthcare reporter at the Wall Street Journal. Thanks for joining us, Peter Thanks for having me on Pharmaceutical company, Eli Lilly has requested the emergency use authorization of an experimental antibody based treatment that they have for Cove in 19. This is similar to what the president was getting this monoclonal antibodies. He got it from a company called Regeneron. But Eli Lilly has something similar. And they're saying that there's works okay in clinical trials that they've been going through already, and they think that they can seek approval as early as next month. Peter, tell us a little bit more about this one. Well, yes, it is a similar approach to what I think A lot of people have heard in the news about one of the treatments that President Trump got and anybody based treatment in this case with easily Lily. What they did was they formed a partnership with another company, where they actually took Ah blood sample from one of the first people in the U. S to recover from covert 19. And they isolated. Certainly antibodies in the blood sample thes air things produced by the immune system that helped someone overcome a virus on infection, and so then, to make a drug out of that, essentially clothes that and a body and make bigger quantities of it, and then Fugit people to test it. And so that's what Eli Lilly has done. They spent the last several months manufacturing doses of this and then testing them in various studies. And so what they're seeking authorization for is to use this antibody based drug as a treatment for people who are recently diagnosed with Covic. And have mild moderate disease and with the hope that the antibody would actually prevent that disease from getting worse and keep people out of the hospital. Until Eli Lilly has some results from the studies. So far, that suggests that this anybody could do that. It's so interesting kind of getting this education as we go through this pandemic. How a lot of these therapeutics and treatments are being made An early on. We were talking about convalescent plasma, literally taking the blood that has antibodies in it from people that have had covert and recovered. And putting that into people. Now we're going through these treatments as he said. We're using those same antibodies and making clones of them and kind of making these treatments from that. So it really is interesting how these things are developing. Tell us about the study. They started it in nursing homes and tell us how it worked, and with the effectiveness of it. The first study for this drug was actually in hospitalized patients, and that was a very small study and they haven't said a ton about that study. But I think they had what they considered promising results. And then they moved on to a somewhat bigger study in Non hospitalized patients. So these would be people who have a diagnosis. Maybe have some symptoms, But they haven't yet got into a severe stage. So they've tested. You know having those people come into a clinic. And giving them the infusion and then seeing how they do. The nursing home aspect of it is from yet another study, where they're actually bringing the antibody. Out to various nursing homes. If that nursing has, or looks like it's going to have an outbreak. If there's one case of cove it what they then do as they test the antibody and UN er residents and staff in a nursing home near to treat any existing diseases that they may have gotten from this emerging, L pray or even for its potential to prevent disease That's called the prophylactic Use of the anybody is to use it as a preventive measure, not only to treat An existing infection. Eli Lilly, As I said earlier. They're hoping they can get this emergency use authorization or at least try to go for in November. But they're saying that they could already have 100,000 doses ready this month and as many as one million by the end of the year, so if they get that authorization, they're ready to go right away. It's very similar to like the vaccine candidates that were going through their producing. Doses and having them ready just in case they get approved. And just to clarify Eli Lilly has already filed for An emergency to use authorization with the FDA. And so it's possible that that decision could come relatively soon. And that would be for the single antibody the main one that I've been talking about to treat these mild to moderate cases. In addition to that they've been testing that the one and a body had been adding a second antibody. And so it's a two drug combination. And that's the one that they are expecting to apply for in November. But in either case, you're right. They are making the doses and they have certain targets for what they can produce. By the end of the year and what they've produced already, it is likely that you know if they were to get a government authorization relatively soon, there would be. I think an imbalance in supply and demand. There would be greater demands. Thantos is available, and so I think there's gonna be some work to do to figure out if there's a certain types of patients that should be. Prioritized and, for instance, Lily said today that it's possible that you could maybe reserved this initial supply of doses maybe reserved for people who are 65 older or are overweight because those are the groups that seem like they are probably most at risk of worsening, too severe disease if there's not a treatment that prevents them Peter Law Office Healthcare reporter at the Wall Street Journal. Thank you very much for joining us my pleasure.

Eli Lilly Wall Street Journal Peter president Peter Loftiest Healthcare Regeneron reporter Peter Law Office Healthcare re Covic Lily U. S Thantos Fugit Trump FDA
"eli lilly" Discussed on MAD MONEY W/ JIM CRAMER

MAD MONEY W/ JIM CRAMER

02:56 min | 1 year ago

"eli lilly" Discussed on MAD MONEY W/ JIM CRAMER

"While the Bulls argued. The safety data was solid. The numbers we saw very little about the treatments actual efficacy credit word Stewart the time and als- at stifle downgraded from Idaho cutting his price target literally in Hass ask based on concerns about its lead drug and more broadly it's technology platform then in August as main competitors. Therapeutics suffered a major setback back and a month later they got fast track designation from the FDA ensure while there was one warning sign. You had very little reason to believe leave. This new drug would be a total bust. I mean yesterday fast. Track the drug. Are they really gonNA track something fast. It doesn't work apparently. Well yes these. Yesterday we have announced that discontinuing to of Duchenne must dispeat- drugs. The clinical trials basis some very disappointing efficacy data. This is these were you can disease where your body can't produce important protein destroyed third waves. Gene therapy was supposed to fix that. But in their words quote the results showed no change from baseline in destroy fin expression unquote unquote despite some promising preclinical data. The drug fail now the companies. Those are the drugs in the works including treatment for Huntington's disease but this was a major blow and it's a blow their almost nobody saw coming when the FDA fast track drug. That's usually a sign that they've done their the homework and they see something very promising but even FDA drops the ball sometimes. We're not the only ones who were taking. Who got taken by on this one? Though since August every single analysts covering wave either rated a by a whole go into this news had six buys and tools people who believed so what we do. Now we own this wave life. These people tweeted me on this. What do you do what do you do well? Look I don't think it's completely lost. It's not toast host. The Huntington drug could be very big drug assuming the data goes your way and the CEO told us to expect it the data very soon. It might be good. I gotTa tell you after what happened with Shay Muscular dystrophy drug though yesterday Ahmad exactly overflowing with confidence in waves technology technology. This has now become a show me story and until we see more evidence that their platform works. I am not going to recommend. It even has come down at creek deal. Here's the bottom mind when you speculate on early stage biotech stocks. There's always a risk that are promising. Drug candidate will blow up up in your face and your stock. We'll get wrecked. That's what happened to wave is sometimes. These meltdowns are very hard to predict. So if you're going to bet on these companies you really need. It'd be aware of the risks and accept the devastating losses.

FDA Bulls Huntington Idaho Hass Stewart Ahmad Shay CEO
"eli lilly" Discussed on KLBJ 590AM

KLBJ 590AM

01:55 min | 1 year ago

"eli lilly" Discussed on KLBJ 590AM

"Nine brought to you by nerds in a flash check this out she got an iPhone or an apple watch detect signs of dementia that is the question the tech giant and Eli Lilly you're trying to answer by seeing of data from the devices can actually help pinpoint early signs of dementia in users so far the study has found that people showing signs of symptoms are cognitive decline on type more slowly Ty plush regularly and sent fewer text messages that healthy participants researchers have noted that there are some limitations to the study and so far haven't drawn any long term collusion our conclusions on this because more analysis is needed but it's pretty intricate I'm done I'm I'm a goner I'll be gone or if if if if it's because you're typing slowly when you're texting or you text less often then I'm done well I'm I'm classic there has to be a pattern established you may not you know when a normal circumstance texted type fast at all I so it's a it's it calculates your patterns over a lengthy period of time I I've always been a slow texture all old ways always so maybe I'm okay then maybe it maybe is just standard operating procedure not listening to me if you're slow texter now if you get slower over time then you may be showing signs of dementia that's what the technology would would check out that's the kind of thing we need to worry about I hate to say the name because I know the dogs it will go crazy but Alexa users are concerned about the device spying on them and now may have a way to opt out good news if you're worried that Alexa might be recording your private a most intimate moments from the bedroom for others to hear Amazon has announces joining apple and Google to allow users to opt out of allowing human review of its voice assess recordings Amazon says only a small fraction of voice recordings are manually reviewed nonetheless.

Eli Lilly Ty Alexa Amazon apple Google
"eli lilly" Discussed on Sawbones: A Marital Tour of Misguided Medicine

Sawbones: A Marital Tour of Misguided Medicine

22:43 min | 1 year ago

"eli lilly" Discussed on Sawbones: A Marital Tour of Misguided Medicine

"We can't do any good experiments to see what it can do for people but if we could reschedule agile it then we could and then we would know what it would do it for the things that works for reschedule it does it look as good on a bumper. I Acre we agree scientists where it starts. The research is the first part which is what kindly Fred Venture said when he introduced at the annual shareholders meeting of Eli Lilly last year a resolution to one he just wanted everybody ready to recognize the history of Eli Lilly growing lots of wheat and we all admit that we did just use a a lot of really stood up at the shareholders meeting and just read the history. I just want you all to know and then to he said Ed and I would ask as a shareholder. Could you lobby the government to reschedule marijuana so that ally can continue its research in this area and start selling it again and a apparently it was voted down <hes> <hes> what hey we'll get him next year. Hey maybe next year. Maybe next year folks. There's always next year. Hey thank you so much for joining us here. Indianapolis <hes> there's there is we owe a great debt to the tax payers for these. There's on medicines as the internal of our program thank you to <hes> Paul suborned for all of his assistance here this evening and we we are going to be back in a moment with my brother my brother may there's going to be a brief intermission at which point you can help yourself to the restroom but but but <hes> please do that please use the bathroom by himself and please Roebuck. Amazon's called the Solomon's book that is going to do it for us this week until next time enemy. Just macaroni always Joe a hole in your head uh-huh <music> maximum fund dot org comedy and culture artists. Don't audience supported uh-huh Yeah Yeah uh-huh yeah yeah the yeah yeah yeah yeah the yeah the the Yeah Yeah Yeah uh-huh yeah yeah the uh-huh

Eli Lilly Ed Fred Venture Indianapolis marijuana Solomon Amazon Paul suborned Joe
"eli lilly" Discussed on Sawbones: A Marital Tour of Misguided Medicine

Sawbones: A Marital Tour of Misguided Medicine

12:59 min | 1 year ago

"eli lilly" Discussed on Sawbones: A Marital Tour of Misguided Medicine

"That's GONNA do for us. <hes> so let's let's not have any further ADO Louis just came back to the show now the thing about this this cannabis part of the story cannabis is a big part of the Eli Lilly story but for some reason an ally lily representatives don't like to talk about it. They don't like to go over like if you read and I've read now several accounts accounts of the history of Eli Lilly you won't find any mention of their cannabis operations in the early years and this is strange because again. This wasn't wasn't just them like all the major pharmaceutical companies were also selling weed alongside all their other medicines medicines that they were selling but this has become like an obsession John and a fascination for someone in particular. This is how I found this story. This gentleman named Fred Finisher who's a former attorney who started working <music> as an Eli Lilly diversification analyst whatever that means and he holds a bunch of shares and Eli Lilly and he was always vehemently anti-drug and then he knew somebody who use marijuana to manage their pain and he saw that it was really effective and so now he's become very pro marijuana. Now he'll tell you he doesn't I use it. He just wants it to be a medicine. Everybody else can use if they need it when wink and and it's funny because if you read descriptions everything I read kept referring to him as like when you see him he's a distinguished gentleman and a blue blazer and he's very much a Marion County Republican. We've we've got y'all. We know what that meant but he really wants. Eli Lilly to talk about how they loved. We'd it's like you like a friend who went to college with that smoked every day and you try to talk about it later and read their kids. That's not really mean anymore. I'm I'm not blazey Bob. I'm just Robert the father of Rebecca and Steven so this this story largely league he has dug up and unearthed and sh- and shared with the world just because he really wants everybody you know like I own shares an ally Lily and they used to love pot and it's true at in in the late eighteen hundreds when everybody else was also on the cannabis bus and selling it for a variety of things like I said it was it was in the pharmacy of the United States. You can find listed marijuana for gout rheumatism tetanus cholera convulsions hysteria hemorrhage whatever pain anything it was sold and used for everything and so it was legitimate medication and there was a particular Taylor member of the Ali'i Lilly company that was really interested in all the things that can do and thought you know what this could be like a big a big part of our business as you know we're. We've got the quinine good..

Eli Lilly cannabis marijuana Fred Finisher Louis quinine Lily Bob United States Marion County John analyst Taylor Robert attorney Steven Rebecca
"eli lilly" Discussed on Sawbones: A Marital Tour of Misguided Medicine

Sawbones: A Marital Tour of Misguided Medicine

15:49 min | 1 year ago

"eli lilly" Discussed on Sawbones: A Marital Tour of Misguided Medicine

"Saw bones is a show about medical history and nothing the hosts as should be taken as medical advice or opinion. It's fun. Can't you just have fun on for an hour and not try to diagnose your mystery boil. We think you've earned it. Just sit back. Relax and enjoy a moment of distraction from that weird growth your worth. It is about the books <music> in your in your property pharmacy. Let's see what the last south hello everyone and welcome to Saab bones apparenlty misguided medicine. I'm a CO host Justin mcelroy Maccarone. It's Kinda for both of us because we're a team so I- average out out cheering and I just take the median in that's right the median is that the average of the mean cosign uh-huh okay. It's okay welcome welcome to Indianapolis City mcelroy. Thank me the welcome everyone. Will you might live here anyway. Some of you probably your hometown we when whenever we get to go on the road and and do shows we try to find topics for saw bones that relate to to where we're going and as I was looking into Indianapolis and stuff at the history and medical history and that kind of thing one of the things I came across which I realize now as I'm about to do the show. Is it foolhardy to go somewhere and like kind of knock on one of their biggest corporations. Oh they love it. They love it and knock is probably strong arm. It's obvious if I know you it's probably celebrate story Nice story we we actually this really happened because we did this. In Salt Lake City we went to Salt Lake City the home of like the country's country's biggest essential oil manufacturers and I I decided I'm just going to talk about how bad they are and so they were loving though because I guess they were tired of their facebook walls just being absolutely full of marketing right so we're we're gonNA talk about Lily. Actually you can see from our like hotel room. You can see like a giant Lilly building yeah it's. I don't know what I don't know which one I assume there are many right away a lot but yeah. It's really large I don't I I guess we go visit maybe tomorrow or maybe not we'll see we'll say we're short of a welcome. PRESENCE MS isn't bad this is like a lot of drug companies that have been around for a really long time occasionally. They dabbled in things that are not are not traditionally accepted as medications today hey or maybe should be. Oh and Eli Lilly doesn't always like to talk about that part of their history but we do so we're going to said I'M GONNA. I'M GONNA call you a furniture. Get your salesman because you're really angry. Letters slammed her or anything so as you may imagine ally lily is named for ally Lily who who was it like a guy and that was his name Eli Lilly he was actually so far so good. It wasn't wasn't born here. He was actually born in Baltimore but he moved around a bit with his family ending up <hes> Kentucky for a while and then back in Indiana where he attended what was Indiana Asbury University which is now Paul and he I love this part of his biography because if you read it it says Lilly became came interested in chemicals as a teen I think a lot of us can relate to that all right Eli me too me into but he was really like he wanted to do..

Eli Lilly Lily Justin mcelroy Maccarone Salt Lake City Indianapolis City Indianapolis salesman facebook Indiana Asbury University Baltimore Indiana Kentucky Letters Paul